Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday
Quick Read
“Working in advocacy is a way to deal with burnout,” said Dr. Jessica Beard, a trauma surgeon at Temple University Hospital in Philadelphia
Quick Read
“I asked him to bring me a gun, and he wanted to know why,” Mr. Cowart later told an interviewer. “I told him, ‘Can’t you see I’m a dead man? I’m going to die anyway, I’ve got to put myself out of this misery.’ He said, in a very caring way, ‘I can’t do that.’ It was the first of many times that Mr. Cowart, who was 25 then, would beg to be allowed to die.”
Quick Read
Plastic surgeons’ Instagram accounts of the weekend trip didn’t note the drug company’s sponsorship, which some ethicists say should be disclosed
Quick Read
Doctor, We Need You in the Writer’s Room, StatMay 15, 2019 |
Daniela Lamas, MD, writes ‘I took a break from the I.C.U. to write on a medical drama. It was a chance to imagine a world where the outcomes followed the script I wanted.’
Quick Read
“This is where we think machine learning has the great opportunity to help us,” said Dr. Daniel Cantillon, a cardiologist who serves as medical director of the CMU. “The challenge is we have to be able to call our shots in advance, and that’s something we’re deeply invested in”
Quick Read
Imagine yourself stuck in the hospital. Would you rather your doctors be well-rested, with a limit on how many hours they can work? Or would you rather they work longer shifts, seeing you through the critical hours of your illness and with fewer handoffs of your care?
Quick Read
When a Treatment Costs $450,000 or More, It Had Better WorkApril 24, 2019 |
Some biotech companies are offering a new way to soften the shock of drug prices: Insurers pay only if the patient improves
Quick Read
